Literature DB >> 26612098

Planning and reporting of quality-of-life outcomes in cancer trials.

S Schandelmaier1, K Conen2, E von Elm3, J J You4, A Blümle5, Y Tomonaga6, R Saccilotto7, A Amstutz7, T Bengough8, J J Meerpohl5, M Stegert7, K K Olu7, K A O Tikkinen9, I Neumann10, A Carrasco-Labra11, M Faulhaber12, S M Mulla12, D Mertz13, E A Akl14, X Sun15, D Bassler16, J W Busse17, I Ferreira-González18, F Lamontagne19, A Nordmann7, V Gloy20, H Raatz7, L Moja21, R Rosenthal22, S Ebrahim23, P O Vandvik24, B C Johnston25, M A Walter26, B Burnand3, M Schwenkglenks6, L G Hemkens7, H C Bucher7, G H Guyatt12, M Briel27, B Kasenda28.   

Abstract

Entities:  

Year:  2015        PMID： 26612098      PMCID： PMC5266092          DOI： 10.1093/annonc/mdv559

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Toxicity and quality of life in published clinical trials for advanced lung cancer.

Authors:  Matjaz Zwitter
Journal:  Support Care Cancer       Date:  2018-04-21       Impact factor: 3.603

2.  Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects.

Authors:  Dmitry Gryaznov; Ayodele Odutayo; Belinda von Niederhäusern; Benjamin Speich; Benjamin Kasenda; Elena Ojeda-Ruiz; Anette Blümle; Stefan Schandelmaier; Dominik Mertz; Yuki Tomonaga; Alain Amstutz; Christiane Pauli-Magnus; Viktoria Gloy; Karin Bischoff; Katharina Wollmann; Laura Rehner; Szimonetta Lohner; Joerg J Meerpohl; Alain Nordmann; Katharina Klatte; Nilabh Ghosh; Ala Taji Heravi; Jacqueline Wong; Ngai Chow; Patrick Jiho Hong; Kimberly Mc Cord; Sirintip Sricharoenchai; Jason W Busse; Arnav Agarwal; Ramon Saccilotto; Matthias Schwenkglenks; Giusi Moffa; Lars G Hemkens; Sally Hopewell; Erik von Elm; Matthias Briel
Journal:  Trials       Date:  2020-10-28       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.